Ted Fjällman Ph.D.

Board member since 2021

Dr Ted Fjällman is a Partner at Flerie Invest. He was the CEO of Prokarium between 2014–2021 and is also a member of the Board at Amarna Therapeutics and a Director of Tekiu Ltd. His previous assignments include positions in clinical research at Sahlgrenska University Hospital and in strategy consulting at Sweden’s Royal Academy of Engineering Sciences. Ted holds a Ph.D. in Biotechnology and Immunology from the University of Guelph, Canada.

Stay Updated

Sign up for the Beactica newsletter to receive our latest news and updates